Bajaj Healthcare Limited announced its unaudited standalone financial results for the quarter ended June 30, 2026, reporting a revenue from operations of Rs. 16,563.17 Lakhs, which reflects a quarter-on-quarter increase of 8.22% compared to Rs. 15,305.75 Lakhs for the quarter ended March 31, 2026, and a year-on-year increase of 11.28% compared to Rs. 14,883.63 Lakhs for the corresponding quarter of the previous year. The profit after tax from continuing operations stood at Rs. 1,389.28 Lakhs, showing a decrease of 28.44% sequentially against Rs. 1,941.28 Lakhs for the previous quarter, but an increase of 14.12% compared to Rs. 1,217.37 Lakhs for the corresponding quarter last year.
| Financial Parameter | Current Quarter (30 June 2026) | QoQ Growth (%) | YoY Growth (%) |
| Revenue from Operations | Rs. 16,563.17 Lakhs | +8.22% | +11.28% |
| Profit After Tax (Continuing Operations) | Rs. 1,389.28 Lakhs | -28.44% | +14.12% |
Bajaj Healthcare Limited is a leading pharmaceutical company engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, and finished formulations, catering to both domestic and international markets with a strong emphasis on quality and healthcare standards.
Leave a Reply